文献速递关节外科

全髋关节置换术前6个月内关节腔内注射透明质酸是否安全:565例患者的回顾性队列研究

Intra-Articular Hyaluronic Acid Injections Less Than 6 Months Before Total Hip Arthroplasty: Is It Safe? A Retrospective Cohort Study in 565 Patients.
PubMed 文献 · J Arthroplasty · 2020-09-21

该回顾性队列研究比较全髋关节置换(THA)术前6个月内接受关节腔内透明质酸(IAHA)注射者与未注射者的并发症率,平均随访52个月(±18)。注射组假体周围感染(PJI)率4% vs 对照组0%(P < .001),术后伤口感染9% vs 3%(P = .01),临床功能评分无显著差异。作者建议IAHA注射后6个月内避免行THA。

要点

  • THA术前6个月内IAHA注射组PJI率4%,对照组0%(P < .001)。
  • 注射组术后伤口感染9% vs 对照组3%(P = .01)。
  • VAS疼痛、mHHS、HOOS评分两组无显著差异。

核心结论

  • 作者认为THA术前6个月或更短时间内行IAHA注射可能增加PJI发生率的风险。
  • 作者建议IAHA给药后6个月内避免行THA。

研究设计与样本

  • 回顾性队列研究,比较THA术前≤6个月接受IAHA注射的113例患者(118髋)与同期无同侧髋注射史的452例患者(495髋)。
  • 平均随访52个月(±18)。

主要发现

  • 注射组与对照组基线特征及PJI危险因素无差异。
  • VAS疼痛评分1.4 vs 1.7分(P = .11)、改良Harris髋关节评分77 vs 75分(P = .09)、髋关节残疾与骨关节炎结局评分79 vs 76分(P = .24),两组均无显著差异。
  • 持续性伤口渗液0% vs 1.2%(P = .60)、血栓栓塞事件0% vs 0.6%(P = 1.00)、假体周围骨折1.7% vs 1.2%(P = .65)、脱位0% vs 0.4%(P = 1.00),两组均无显著差异。
  • 注射组PJI发生率4% vs 对照组0%(P < .001),术后伤口感染9% vs 3%(P = .01),注射组均更高。

临床怎么用

  • 作者建议IAHA给药后6个月内避免行THA。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intra-articular hyaluronic acid (IAHA) can be injected into an osteoarthritic hip joint to reduce pain and to improve functionality. Several studies report IAHA to be safe, with minor adverse effects that normally disappear spontaneously within a week. However, intra-articular corticosteroids prior to total hip arthroplasty (THA) have been associated with increased infection rates. This association has never been investigated for IAHA and THA. We aimed to assess the influence of IAHA on the outcome of THA, with an emphasis on periprosthetic joint infection (PJI). METHODS: At a mean follow-up of 52 months (±18), we compared complication rates, including superficial and deep PJIs, of THA in patients who received an IAHA injection ≤6 months prior to surgery (injection group) with that of patients undergoing THA without any previous injection in the ipsilateral hip (control group). One hundred thirteen patients (118 hips) could be retrospectively included in the injection group, and 452 patients (495 hips) in the control group. RESULTS: No differences in baseline characteristics nor risk factors for PJI between the 2 groups were found. The clinical outcomes in terms of VAS pain scores (1.4 vs 1.7 points, P = .11), modified Harris Hip Scores (77 vs 75 points, P = .09), and Hip disability and Osteoarthritis Outcome Scores (79 vs 76 points, P = .24) did not differ between the injection group and the control group. Also, complications in terms of persistent wound leakage (0% vs 1.2%, P = .60), thromboembolic events (0% vs 0.6%, P = 1.00), periprosthetic fractures (1.7% vs 1.2%, P = .65), and dislocations (0% vs 0.4%, P = 1.00) did not differ. However, in the injection group there was a higher rate of PJIs (4% vs 0%, P < .001) and postoperative wound infections (9% vs 3%, P = .01), compared to the control group. CONCLUSION: Our findings suggest that IAHA performed 6 months or less prior to THA may pose a risk for increased rates of PJI. We recommend refraining from performing THA within 6 months after IAHA administration.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Colen S, Hoorntje A, Maeckelbergh L, et al. Intra-Articular Hyaluronic Acid Injections Less Than 6 Months Before Total Hip Arthroplasty: Is It Safe? A Retrospective Cohort Study in 565 Patients. J Arthroplasty. 2020. PMID: 33097337. doi:10.1016/j.arth.2020.09.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。